PhD student, cardiologist, Department of Biochemistry, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Agnė Liuizė (Abramaviciute) is a cardiologist and PhD student at the Lithuanian University of Health Sciences, Kaunas, Lithuania. She completed her Master’s degree in Medicine and obtained her medical doctor qualification in 2017. In 2021, she achieved professional cardiologist qualifications and passed the European General Examination in Cardiology. Agnė is currently pursuing PhD studies in the Department of Biochemistry, focusing on the molecular mechanisms underlying atherosclerosis. Alongside her academic work, she practices cardiology at Kaunas Clinics, contributing to both clinical care and research. Agnė has authored six scientific publications and is passionate about advancing cardiovascular medicine, particularly in understanding the complex biochemical factors influencing cardiovascular diseases. She aims to improve patient outcomes through her research on oxidative stress, inflammation, and endothelial damage.
Education
Agnė Liuizė graduated from the Lithuanian University of Health Sciences Hospital in 2017 with a Master’s degree in Medicine, which also qualified her as a medical doctor. She obtained her professional cardiologist qualification in 2021 after completing residency training. During this time, she also passed the European General Examination in Cardiology, marking a significant milestone in her academic and clinical journey. In October 2023, Agnė began her PhD studies at the Department of Biochemistry, Lithuanian University of Health Sciences. Her research focuses on exploring the role of cellular matrix proteins, cytokines, and oxidative stress in cardiovascular disease development, particularly atherosclerosis. Agnė has always demonstrated a strong commitment to advancing her knowledge in both clinical practice and scientific research, ensuring a balanced approach to her academic and medical career.
Experience
Agnė Liuizė’s clinical career began in 2021 when she obtained her professional cardiologist qualification. From September to December 2021, she worked as a cardiologist at Kaunas Hospital, Lithuanian University of Health Sciences Hospital. Since January 2022, she has been employed as a cardiologist at the Kaunas Clinics, Lithuanian University of Health Sciences Hospital. Her clinical experience has allowed her to apply her medical knowledge to diagnosing and treating cardiovascular diseases while collaborating closely with multidisciplinary teams. In parallel with her clinical work, Agnė has focused on her PhD studies in the Department of Biochemistry, further enhancing her expertise in cardiovascular research. Her academic experience, combined with hands-on clinical practice, allows Agnė to contribute significantly to both patient care and scientific advancements in the field of cardiology. She continues to make an impact in both the clinic and the laboratory through her research on atherosclerosis.
Research Focus
Agnė Liuizė’s research focuses on the molecular mechanisms involved in the development of atherosclerosis. Specifically, her PhD project examines the role of cellular matrix proteins, including thrombospondins, which are involved in tissue remodeling and fibrosis. She investigates the inflammatory markers and cytokines, such as GDF-15, TNF-alpha, and TGF-beta, which play key roles in cardiovascular diseases. Additionally, Agnė explores endothelial damage markers like endocan and vimentin, which are important for understanding vascular injury. Her research also delves into oxidative stress, measuring markers like protein carbonyls, oxidized lipoproteins, and paraoxonase-1 (POX-1), which contribute to the pathological processes in atherosclerosis. By investigating these molecular markers, Agnė aims to identify potential therapeutic targets for improving cardiovascular health and preventing atherosclerosis-related complications. Her research is not only relevant to understanding disease mechanisms but also critical in advancing diagnostic and therapeutic strategies for cardiovascular patients.
Publications:
- TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis 📖
- Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets 💉
- Relationship between Oxidative Stress and Left Ventricle Markers in Patients with Chronic Heart Failure 💔